# FBT holdings and overlap

First Trust NYSE Arca Biotechnology Index Fund (FBT) holds 30 positions in its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21. Its three largest are Corcept Therapeutics (CORT) at 5.60%, NeoGenomics (NEO) at 5.12% and Veracyte (VCYT) at 5.10%, and its ten largest make up 43.2% of the fund.

First Trust NYSE Arca Biotechnology Index Fund, Health Care, First Trust.

Canonical page: https://tickerinside.com/etf/fbt/
Holdings from FBT's SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21.
Licence: CC BY 4.0, attribution to TickerInside. Measurements, not investment advice.

## Largest positions, SEC Form N-PORT for the period ended 2026-06-30

| Rank | Ticker | Company | Weight |
| --- | --- | --- | --- |
| 1 | CORT | Corcept Therapeutics | 5.6% |
| 2 | NEO | NeoGenomics | 5.12% |
| 3 | VCYT | Veracyte | 5.1% |
| 4 | BRKR | Bruker | 4.32% |
| 5 | ALKS | Alkermes | 4.24% |
| 6 | [ILMN](https://tickerinside.com/stock/ilmn/) | Illumina | 3.92% |
| 7 | KRYS | Krystal Biotech | 3.87% |
| 8 | NTRA | Natera | 3.79% |
| 9 | AXSM | Axsome Therapeutics | 3.71% |
| 10 | NBIX | Neurocrine Biosciences | 3.53% |
| 11 | TECH | Bio-Techne | 3.43% |
| 12 | ARWR | Arrowhead Pharmaceuticals | 3.38% |
| 13 | [BIIB](https://tickerinside.com/stock/biib/) | Biogen | 3.37% |
| 14 | EXEL | Exelixis | 3.32% |
| 15 | [INCY](https://tickerinside.com/stock/incy/) | Incyte | 3.18% |
| 16 | ARGX | Argenx SE | 3.13% |
| 17 | HALO | Halozyme Therapeutics | 3.11% |
| 18 | [VRTX](https://tickerinside.com/stock/vrtx/) | Vertex Pharmaceuticals | 3.07% |
| 19 | RGEN | Repligen | 3.07% |
| 20 | BMRN | BioMarin Pharmaceutical | 2.83% |
| 21 | [AMGN](https://tickerinside.com/stock/amgn/) | Amgen | 2.78% |
| 22 | BNTX | BioNTech SE | 2.63% |
| 23 | GMAB | Genmab A/S | 2.62% |
| 24 | UTHR | United Therapeutics Corporation | 2.56% |
| 25 | ALNY | Alnylam Pharmaceuticals | 2.52% |

All 30 positions with weights: https://tickerinside.com/api/v1/fund/fbt.json

Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-06-30, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set: https://tickerinside.com/etf/category/

## How is FBT split by sector and country?

In its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21, FBT is 100.0% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value. By country, 91.6% of FBT is in the United States, 3.1% in Belgium, 2.6% in Germany and 2.6% in Denmark.

| Sector | Weight |
| --- | --- |
| Health care | 100.0% |

| Country | Weight |
| --- | --- |
| United States | 91.6% |
| Belgium | 3.1% |
| Germany | 2.6% |
| Denmark | 2.6% |

How these are measured: https://tickerinside.com/how-the-numbers-are-produced/#sectors


## What did FBT hold in its SEC reports since 2019?

In FBT's SEC filings, its largest position went from ACADIA Pharmaceuticals Inc. (ACAD) at 5.17% on 2019-09-30 to Corcept Therapeutics Incorporated (CORT) at 5.60% on 2026-06-30, across 28 quarterly reports.

| Report for | Positions | Largest position | Ten largest |
| --- | --- | --- | --- |
| 2019-09-30 | 29 | ACAD 5.17% | 39.8% |
| 2019-12-31 | 29 | ICPT 5.36% | 38.9% |
| 2020-12-31 | 29 | RARE 4.79% | 40.1% |
| 2021-12-31 | 29 | ACAD 4.54% | 39.1% |
| 2022-12-30 | 29 | EXAS 4.45% | 37.9% |
| 2023-12-31 | 30 | RARE 4.23% | 37.6% |
| 2024-12-31 | 30 | EXEL 4.37% | 39.3% |
| 2025-12-31 | 30 | EXAS 5.15% | 39.8% |
| 2026-06-30 | 30 | CORT 5.60% | 43.2% |

The first report, then the last of each year, of the 28 reports FBT filed on SEC Form N-PORT from 2019-09-30 to 2026-06-30; companies are keyed by their ticker today. Every position of every report: https://tickerinside.com/api/v1/quarterly/fbt.json; at any date: https://tickerinside.com/api/v1/history/fbt/{date}.json. How these are read: https://tickerinside.com/how-the-numbers-are-produced/#sec-history
## Key figures

| Measure | Value |
| --- | --- |
| Expense ratio, SEC filing 2026-04-30 | 0.55% |
| Positions, N-PORT 2026-06-30 | 30 |
| Weight in the ten largest, N-PORT 2026-06-30 | 43.2% |

## What does FBT share with other ETFs?

| ETF | Overlap by weight | Of FBT held there | Of that ETF in FBT | Companies in both |
| --- | --- | --- | --- | --- |
| PBE | 45.2% | 50.6% | 61.0% | 16 |
| IBB | 41.0% | 89.3% | 60.8% | 28 |
| BBH | 41.0% | 47.9% | 78.9% | 16 |
| IBBQ | 30.4% | 74.7% | 49.8% | 24 |
| GNOM | 27.7% | 37.2% | 32.3% | 11 |
| XBI | 26.1% | 60.0% | 26.1% | 19 |
| BMED | 23.7% | 43.1% | 28.9% | 13 |
| IBRN | 16.6% | 16.6% | 21.2% | 5 |
| PJP | 16.3% | 19.0% | 23.9% | 6 |
| PTH | 14.4% | 24.9% | 14.4% | 6 |
| IDNA | 14.3% | 14.4% | 16.0% | 5 |
| RSPH | 13.1% | 24.5% | 13.1% | 8 |


FBT's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21. BBH's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. The other ETFs' holdings are from their issuers' latest files.

Method: https://tickerinside.com/how-the-numbers-are-produced/

## Cite this page

TickerInside, First Trust NYSE Arca Biotechnology Index Fund (FBT), holdings from SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21, https://tickerinside.com/etf/fbt/, CC BY 4.0

    <a href="https://tickerinside.com/etf/fbt/">TickerInside</a> (https://tickerinside.com/etf/fbt/)